 |
 |
 |
|
Evaluation of the Drug Interaction Potential Between the Pharmacokinetic Enhancer Cobicistat and Tenofovir Disoproxil Fumarate in Healthy Subjects
|
|
|
Reported by Jules Levin
14th International Workshop on Clinical Pharmacology of HIV Therapy
April 22-24, 2013
Amsterdam, the Netherlands
J M Custodio, W Garner, F Jin, H Cao, M Hepner, B P Kearney, and S Ramanathan
Gilead Sciences, Inc., Foster City, CA 94404






|
|
|
 |
 |
|
|